Overview

A Study to Assess the Efficacy and Safety of Eltrombopag as a Rescue of Isolated Chemotherapy-induced Thrombocytopenia

Status:
Unknown status

Trial end date:
2019-08-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is evaluate the efficacy and safety of eltrombopag as a rescue of isolated chemotherapy-induced thrombocytopenia in patients with solid tumor .

Phase:

Phase 3

Details

Lead Sponsor:

Chang Gung Memorial Hospital

Collaborators:

GlaxoSmithKline
Novartis